RetroSense Therapeutics
acquired by AllerganAnn Arbor, US · Founded 2014 · Delaware LLC · 3 known investors
First-in-class optogenetic therapy for retinal diseases; acquired by Allergan.
Biotech
Founders & leadership
RetroSense Therapeutics was founded in 2014 by Sean Ainsworth.
SA
Sean AinsworthFounder
Board
TC
Terry CrossBoard director
KK
Kenneth KouskyBoard director
CG
Cam GallagherBoard director
GL
George LasezkayBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 1 round · 2015
▶$4.6MraisedOct 2015 · 22 investors · BiotechnologyRule 506(b)
▶$4.6MraisedOct 2015 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Terry CrossDirector
- Cam GallagherDirector
- Sean AinsworthExecutive Officer, Director
- George LasezkayDirector
- Kenneth KouskyDirector
- Offering amount
- $5M
- Amount sold
- $4.6M
- Minimum investment
- $4
- First sale
- Aug 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does RetroSense Therapeutics do?
- First-in-class optogenetic therapy for retinal diseases; acquired by Allergan.
- Who founded RetroSense Therapeutics?
- RetroSense Therapeutics was founded by Sean Ainsworth in 2014.
- Who are RetroSense Therapeutics's investors?
- RetroSense Therapeutics's investors include Boston Harbor Angels, ExSight Ventures, GREAT LAKES BAY VENTURE.
- How much funding has RetroSense Therapeutics raised?
- RetroSense Therapeutics has disclosed $4.6M raised across 1 round.
- Who acquired RetroSense Therapeutics?
- RetroSense Therapeutics was acquired by Allergan.
- Where is RetroSense Therapeutics headquartered?
- RetroSense Therapeutics is headquartered in Ann Arbor, US.